Hunan GM Biotechnology Co., Ltd. (GM ACCURATE DIAGNOSIS) is a national high-tech enterprise focusing on the research, development, production and sales of animal in vitro diagnostic reagents and equipment. It is the first to pass the dynamic acceptance of Hunan Province's veterinary molecular and immunodiagnostic GMP. As a provincial new R&D institution, the company is committed to becoming a leader in animal disease precision diagnosis technology and solutions. More than 60% of the staff have a postgraduate degree or above, and the annual R&D investment accounts for more than 20% of the revenue.
The various fluorescent PCR reagents and antibody detection reagents developed by the company are widely recognized in the breeding industry. Three out of every four listed pig companies are using Guanmu diagnostic reagents. Relying on the support of top institutions such as the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, the company has taken the lead in developing a number of industry-leading products including African swine fever virus chimeric strain differential diagnostic reagents, providing strong guarantees for food safety and sustainable development of animal husbandry.
By establishing an animal disease precision diagnosis platform, the company actively promotes the concept of precise detection to guide precise epidemic prevention, publishes more than 300 technical articles and videos, holds more than 50 special live broadcasts, and hosts or undertakes a number of large-scale industry exchange activities including the "Youth Veterinary Summit", and continues to empower the industry.
Guanmu Precision Diagnosis insists on being customer-centric and innovation-driven, continuously improving the quality of products and services, helping breeding companies make good use of testing centers, manage their health well, and achieve sustainable development.